Brain Tumor Clinical Trial
Official title:
Effect of Acupuncture on Inflammation and Immune Function After Craniotomy
NCT number | NCT02761096 |
Other study ID # | 20152152 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | April 2016 |
Est. completion date | November 2017 |
Verified date | February 2019 |
Source | Kyunghee University Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to evaluate the effect of acupuncture on inflammation and immune function after craniotomy. This study will be a single-center, parallel group clinical trial that will be conducted at Kyung Hee University Hospital at Gangdong, Seoul, Korea.
Status | Completed |
Enrollment | 44 |
Est. completion date | November 2017 |
Est. primary completion date | May 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: Participants must meet all of the following criteria in order to be included: 1. planning to undergo regular craniotomy performed for an unruptured aneurysm, facial spasm, or brain tumor; 2. age > 18 years; 3. acupuncture treatment that can start within 48 h after craniotomy; 4. voluntary participation and provision of signed informed consent form. Exclusion Criteria: Participants with any of the following conditions will be excluded: 1. serum C-reactive protein (CRP) level = 1.0 mg/dl before craniotomy; 2. a condition other than an unruptured aneurysm, facial spasm, or brain tumor as an indication for craniotomy; 3. craniotomy performed for infectious brain diseases such as brain abscess or subdural empyema; 4. medication use that can affect the immune system or white blood cell (WBC) count, such as immunosuppressive drugs, steroids, or anticancer drugs or use of these medications within one month prior to the craniotomy; 5. a history of surgery at the same site; 6. emergency surgery; or 7. a severe medical disease, e.g. congestive heart failure, chronic renal failure. |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Kyung Hee University Hospital at Gangdong | Seoul |
Lead Sponsor | Collaborator |
---|---|
Kyunghee University Medical Center | Kyunghee University |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Serum CRP | Turbidimetric immunoassay will be performed for measurement of CRP. A blood sample will be drawn from the brachial vein at a fixed time in the morning before breakfast. | 2 days after surgery | |
Secondary | Serum CRP | Turbidimetric immunoassay will be performed for measurement of CRP. A blood sample will be drawn from the brachial vein at a fixed time in the morning before breakfast. | within 48 h before the surgery, 4 days after surgery and 7 days after surgery | |
Secondary | Serum erythrocyte sedimentation rate (ESR) | The photometrical capillary method will be performed for measurement of ESR. A blood sample will be drawn from the brachial vein at a fixed time in the morning before breakfast. | within 48 h before the surgery, 2 days after surgery, 4 days after surgery and 7 days after surgery | |
Secondary | Serum TNF-a | Enzyme-linked immunosorbent assay (ELISA) will be performed for measurement A blood sample will be drawn from the brachial vein at a fixed time in the morning before breakfast. | within 48 h before the surgery, 2 days after surgery, 4 days after surgery and 7 days after surgery | |
Secondary | Serum IL-1ß | Enzyme-linked immunosorbent assay (ELISA) will be performed for measurement A blood sample will be drawn from the brachial vein at a fixed time in the morning before breakfast. | within 48 h before the surgery, 2 days after surgery, 4 days after surgery and 7 days after surgery | |
Secondary | Serum IL-6 | Enzyme-linked immunosorbent assay (ELISA) will be performed for measurement A blood sample will be drawn from the brachial vein at a fixed time in the morning before breakfast. | within 48 h before the surgery, 2 days after surgery, 4 days after surgery and 7 days after surgery | |
Secondary | fever | Any fever with a body temperature over 38? will be recorded on the case report form. | During the post operation day to 7 days after operation day. Body temperature will be measured at 6:00, 10:00, 18:00, and 22:00 every day. | |
Secondary | use of additional antibiotics | Use of additional antibiotics will be recorded on the case report form. | During the post operation day to 7 days after operation day | |
Secondary | infection sign | Infections such as pneumonia or urinary tract infections will be recorded on the case report form. | During the post operation day to 7 days after operation day, |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05023434 -
A Study to Measure the Effect of Brain Stimulation on Hand Strength and Function in Patients With Brain Tumors
|
||
Completed |
NCT04474678 -
Quality Improvement Project - "My Logbook! - I Know my Way Around!"; ("Mein Logbuch - Ich Kenne Mich Aus!")
|
N/A | |
Completed |
NCT02768389 -
Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma
|
Early Phase 1 | |
Terminated |
NCT01902771 -
Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors
|
Phase 1 | |
Recruiting |
NCT03175224 -
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
|
Phase 2 | |
Recruiting |
NCT03286335 -
Local Control, Quality of Life and Toxicities in Adults With Benign or Indolent Brain Tumors Undergoing Proton Radiation Therapy
|
N/A | |
Recruiting |
NCT05968053 -
Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
|
||
Recruiting |
NCT05358340 -
Dual Perfusion Imaging for Characterizing Vascular Architecture of Brain Lesions
|
N/A | |
Recruiting |
NCT03276676 -
[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors
|
Phase 2 | |
Completed |
NCT02851355 -
Follow-up Survey of Patients Who Were Treated for Medulloblastoma or Primitive Neuroectodermal Tumors of the Central Nervous in Norway
|
||
Completed |
NCT02713087 -
Vasopressor Effects in Anesthetized Patients
|
Phase 4 | |
Completed |
NCT02409121 -
A Novel Health Information Technology System (BMT Roadmap) for Pediatric BMT Patients and Caregivers
|
N/A | |
Completed |
NCT02558569 -
The Use of Fentanyl in General Anesthesia for Craniotomy With or Without 0.5% Levobupivacaine Scalp Block
|
Phase 4 | |
Terminated |
NCT02674945 -
Understanding and Improving Quality of Life Through a Wireless Activity Tracker: Observational Phase
|
||
Withdrawn |
NCT02165995 -
Use of Navigated Transcranial Magnetic Stimulation (nTMS) in Generated Motor and Language Mapping to Evaluate Brain Recovery Following Surgery
|
N/A | |
Withdrawn |
NCT01202539 -
Real-time Assessment of Frameless Intrafraction Motion
|
||
Completed |
NCT01171469 -
Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor
|
Phase 1 | |
Terminated |
NCT01044966 -
A Study of Intraventricular Liposomal Encapsulated Ara-C (DepoCyt) in Patients With Recurrent Glioblastoma
|
Phase 1/Phase 2 | |
Completed |
NCT00760409 -
Differentiating Recurrent Brain Tumor Versus Radiation Injury Using MRI
|
N/A | |
Completed |
NCT00503204 -
Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour
|
Phase 1 |